Yahoo Finance Site Map
ArticlesFor a comprehensive guide to our content, please see the Site Index
SiteMap 2023 > 03 > 01
Other dates of the month:
- Jamf Holding (JAMF) Surpasses Q4 Earnings and Revenue Estimates
- Health Catalyst (HCAT) Reports Q4 Loss, Tops Revenue Estimates
- Revance Therapeutics, Inc. (RVNC) Reports Q4 Loss, Tops Revenue Estimates
- Avidity Biosciences, Inc. (RNA) Reports Q4 Loss, Tops Revenue Estimates
- Davison County bans TikTok on county-owned devices
- CPABC: B.C.’s Budget 2023 Aims to Boost Housing Supply
- Major League Rugby Signs Partnership with OVAL3
- Australia economy slows in Q4 as inflation squeezes consumers
- Coupang’s Slowing Sales Growth Mars Second Quarterly Profit
- $4.6 Million in Federal Funding Approved for Black River Initiative
- NYC Mayor Adams’ administration supports anti-fat discrimination bill; more tepid on tattoos
- ComScore (SCOR) Reports Q4 Loss, Tops Revenue Estimates
- BRP Group (BRP) Surpasses Q4 Earnings and Revenue Estimates
- Gulfport Energy (GPOR) Beats Q4 Earnings and Revenue Estimates
- Corcept Therapeutics (CORT) Lags Q4 Earnings and Revenue Estimates
- Inter Parfums (IPAR) Q4 Earnings and Revenues Surpass Estimates
- ICF International (ICFI) Q4 Earnings and Revenues Surpass Estimates
- Arteris, Inc. (AIP) Reports Q4 Loss, Lags Revenue Estimates
- Montrose Environmental (MEG) Reports Q4 Loss, Lags Revenue Estimates
- Kevzara® (sarilumab) Approved by FDA as First and Only Biologic Indicated for Patients with Polymyalgia Rheumatica
- Vibe Conference Announces the Top Beverage Companies at the 2023 Supplier Awards Ceremony
- The BC Bud Co Announces Simon Tso as Chief Financial Officer
- FOMO3D: Arbitrum Launches Game dApp, Prize Pot Hits 7 ETH Within Hours of Release
- Metis Energy Limited's (SGX:L02) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
- Exclusive-Biden administration to move on Midwest ethanol-blended gasoline rule this week -sources
- Rochester's Diversity Council nonprofit to close down
- Myriad Genetics (MYGN) Reports Q4 Loss, Tops Revenue Estimates
- Oak Street Health, Inc. (OSH) Reports Q4 Loss, Tops Revenue Estimates
- Red Robin (RRGB) Reports Q4 Loss, Tops Revenue Estimates
- Flyware (FLYW) Reports Q4 Loss, Tops Revenue Estimates
- Shoals Technologies Group (SHLS) Tops Q4 Earnings and Revenue Estimates
- Silk Road Medical (SILK) Reports Q4 Loss, Tops Revenue Estimates
- Masimo (MASI) Q4 Earnings and Revenues Beat Estimates
- Amphastar Pharmaceuticals (AMPH) Q4 Earnings and Revenues Beat Estimates
- Natera (NTRA) Reports Q4 Loss, Tops Revenue Estimates
- UPDATE 3-Apple supplier Foxlink says working to resume production after India fire
- Apple supplier Foxlink says working to resume production after India fire
- First Mover Asia: NFTs Have a ‘Digital First Sale’ Problem
- BluMetric Announces Q1 2023 Financial Results
- UPDATE 1-Brazil's Cosan posts profit down 37% after slump in energy unit
- Biden conditions for chip funding cause 'heartburn,' industry insiders say
- Sparta Updates Status of Annual Financial Filings Following MCTO
- Repare Therapeutics Inc. (RPTX) Reports Q4 Loss, Tops Revenue Estimates
- PetIQ (PETQ) Reports Q4 Loss, Misses Revenue Estimates
- Compass, Inc. (COMP) Reports Q4 Loss, Lags Revenue Estimates
- Endeavor Group (EDR) Reports Q4 Loss, Lags Revenue Estimates
- Payoneer Global Inc. (PAYO) Reports Q4 Loss, Tops Revenue Estimates
- Lyell Immunopharma (LYEL) Reports Q4 Loss, Tops Revenue Estimates
- Muscular Dystrophy Association Celebrates FDA Approval of Skyclarys, First Ever Treatment for Friedreich’s Ataxia from Reata Pharmaceuticals
- FOREX-Dollar advances, Aussie slides as Australia economy slows